This application is a request for continued funding of the Training Program in Signal Transduction and Cancer (T32 CA070085) at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, an NCI-funded comprehensive cancer center. The Training Program in Signal Transduction and Cancer received funding from the NCI in 1997 and renewal funding in 2002. The Training Program brings together faculty and postdoctoral fellows with a focused interest in receptors, growth factors and signal transduction pathways and trains postdoctoral fellows for a career in signal transduction and cancer. The preceptors are established NIH funded investigators and they belong to all five basic science programs of the Cancer Center: Viral Oncogenesis; Tumor Invasion, Metastasis and Angiogenesis; Hormones and Signal Transduction in Cancer, Cancer Genes and Molecular Regulation and Cancer Cell Biology. Program cohesion is accomplished through organized meetings, journal clubs and seminars and symposia. These activities provide a structured forum for sharing the latest scientific results and promote intellectual collaborations and interactions. Over the last nine years the Training Program has successfully trained 24 postdoctoral fellows, including three minority trainees. Trainees are required to attend the educational activities (laboratory meetings, journal club, seminars, symposia) associated with the Program in addition to their laboratory research. All trainees enroll in the Ethics Colloquium. We are currently making appointments for Year 10 and advertisements have been placed in the journal Science to attract the best candidates to join the Program. Based on our expectation that we will maintain the same candidate pool of highly qualified applicants we request continued funding for the four postdoctoral positions per year for a period of five years in the present application. This will enable us to continue focused postdoctoral training in Signal Transduction and Cancer at the Robert H. Lurie Comprehensive Cancer Center. In view of the fact that cancer is the second leading cause of death in the U.S., our Training Program in Signal Transduction and Cancer has direct relevance to this important public health issue. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA070085-12
Application #
7421027
Study Section
Subcommittee G - Education (NCI)
Program Officer
Jakowlew, Sonia B
Project Start
1997-05-01
Project End
2012-04-30
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
12
Fiscal Year
2008
Total Cost
$191,697
Indirect Cost
Name
Northwestern University at Chicago
Department
Pathology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Bell, Jonathan B; Eckerdt, Frank; Dhruv, Harshil D et al. (2018) Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation. Mol Cancer Res 16:32-46
Sang, Youzhou; Li, Yanxin; Song, Lina et al. (2018) TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3. Cancer Res 78:1792-1804
Pangeni, Rajendra P; Zhang, Zhou; Alvarez, Angel A et al. (2018) Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma. Epigenetics 13:432-448
Wang, Lu; Ozark, Patrick A; Smith, Edwin R et al. (2018) TET2 coactivates gene expression through demethylation of enhancers. Sci Adv 4:eaau6986
Murmann, Andrea E; Gao, Quan Q; Putzbach, William E et al. (2018) Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells. EMBO Rep 19:
Putzbach, William; Gao, Quan Q; Patel, Monal et al. (2018) DISE: A Seed-Dependent RNAi Off-Target Effect That Kills Cancer Cells. Trends Cancer 4:10-19
Ladomersky, Erik; Zhai, Lijie; Lenzen, Alicia et al. (2018) IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma. Clin Cancer Res 24:2559-2573
Gilles, Laure; Arslan, Ahmet Dirim; Marinaccio, Christian et al. (2017) Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis. J Clin Invest 127:1316-1320
Wang, Lu; Collings, Clayton K; Zhao, Zibo et al. (2017) A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism. Genes Dev 31:2056-2066
Arslan, A D; Sassano, A; Saleiro, D et al. (2017) Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma. Oncogene 36:6006-6019

Showing the most recent 10 out of 100 publications